Breast Reduction Vertical Incision in Beaumont Canada
Breast reduction is an operation that is usually considered a reconstructive procedure and is many times covered by insurance plans. The surgery is performed to make the breasts smaller, as well as lift the breasts to a more youthful position. The purpose of the surgery is to alleviate back and neck pain as well as to aid in hygiene in the folds underneath the breasts.
Marks are made on the skin according to the type of reduction planned by the patient and the surgeon. This is usually performed before the patient is taken back to the operating room with the patient in a sitting or standing position.
With the patient now asleep, incisions are made around the predetermined marks on the breasts.
The breast tissue is removed with an electro cautery instrument that cauterizes bleeding vessels while it removes the breast tissue. This helps reduce the amount of blood that is lost during the operation.
The incisions are closed with sutures.
The patient is placed in a compression garment or bra. Compression garments are an important part of the recovery process. The garment provides support, comfort and helps to minimize swelling. The patient is usually wearing a bra or some type of supportive garment at all times, except when showering. Healing time is approximately three months. Scarring is variable and often depends on the patient's ability to heal.
More Beaumont info...
Beaumont See
Texas Energy Museum, 600 Main Street, ? +1 409-833-5100 (info@texasenergymuseum.org, fax: +1 409-833-4282), [1]. Tu-Sa 9AM-5PM; Su 1PM-5PM. $2/1 (Adults/Seniors 65+ & Children under 12).
Plastic Surgery News...
- According to a report by PharmaTimes, the Department of Health has informed UK manufacturers of medicines that the current pricing deal that sets the cost of prescription drugs to the National Health Service is being scrapped at the end of the summer.
The Department of Health has sent out a letter serving a 6-month notice stating that the current Pharmaceutical Price Regulation Scheme (PPRS) will be replaced on the 1st of September 2008.
The move was prompted by an Office of Fair Trading report, which claimed that the NHS could save up to £500 million a year by choosing the cheapest alternative on a range of popular medicines, and recommended that reforming the PPRS would help deliver greater benefit to patients.
- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Pravastatin Sodium Tablets, 80 mg.